Announced
Completed
Financials
Sources
Tags
pharmaceuticals
biotechnology
treatment development
Biotechnology
United States
Private
Acquisition
Completed
Friendly
Single Bidder
Synopsis
Sale of Confluence Life Sciences, a biotechnology company focused on the kinase inhibitors to treat inflammatory and immunological disorders and cancer, to Aclaris Therapeutics.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.